Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech CEO
Pharma
Turbulent times at Aurinia with renewed investor activism
Four Aurinia board directors—including CEO Peter Greenleaf—and the proposed exec compensation recently failed to win majority shareholder support.
Angus Liu
Aug 13, 2024 11:30am
Ori reveals automated cell therapy production platform
May 29, 2024 3:01pm
Neurocrine elevates BD chief to succeed founder and CEO
May 29, 2024 11:42am
Argenx isn't sweating over Vyvgart competitors: exec
May 9, 2024 4:56pm
Biogen's fortunes are trending upward thanks to its new launches
Apr 24, 2024 11:24am
FibroGen, Kind Pharma settle trade secrets theft dispute
Apr 19, 2024 12:53pm
